Pubrio sells to AI agents - live prices and self-serve payment

The agent storefront at https://agents.pubrio.com/llms.txt?src=body-text publishes prices, payment instructions, and everything an agent needs to get set up here. Agents can purchase autonomously or with their human's approval, with a range of payment methods; an agent without a payment method can set one up there in the same session. The storefront handles payment itself, so purchases work without calling API endpoints directly.

pubrio
BioVentrix logo

BioVentrix

+1
醫療器材22 employeesFounded 2003🇺🇸 美國
總部
🇺🇸120 Forbes Blvd, Mansfield, Massachusetts 02048, Us (+1)
行業
醫療器材
員工
22
成立年份
2003
排名
#1,792,666

BioVentrix is a medical device company focused on developing innovative treatments for heart failure. Founded in 2003, the company aims to improve cardiac function in patients suffering from this condition. BioVentrix is known for its flagship product, the Revivent TC Transcatheter Ventricular Enhancement System, which is used alongside the Less Invasive Ventricular Enhancement (LIVE) procedure. This system helps restore the shape and performance of the left ventricle in patients with ischemic heart failure. The company is also involved in the ALIVE Clinical Study, which evaluates the effectiveness of the Revivent TC System in treating symptomatic heart failure patients with specific types of left ventricular scarring. Additionally, BioVentrix offers comprehensive heart failure programs to assist hospitals in establishing integrated care models, including financial and operational plans. With headquarters in Mansfield, Massachusetts, and San Ramon, California, BioVentrix targets healthcare institutions and medical professionals specializing in cardiology.

專長
醫療器材製藥產業醫療保健

擴張情報

全新 · Pubrio 獨家

我們正在追蹤 BioVentrix 的市場擴張

全球擴張

即時
過去 90 日
階段
探索中0投入中0拓展中0規模化中0
近期動態
推進中30天
新增90天

活動脈搏

過去 90 日內有 2 個訊號。

過去 90 日
招聘
0
無活動
市場推廣與公關
0
無活動
產品與技術
2↓ 已結束
雲端足跡
+2個類別已鎖定
已顯示 5 個中的 3 個
值得了解

關於 BioVentrix 的常見問題

關於 BioVentrix 業務、市場及增長訊號的快速解答。

BioVentrix is a medical device company focused on developing innovative treatments for heart failure. Founded in 2003, the company aims to improve cardiac function in patients suffering from this condition. BioVentrix is known for its flagship product, the Revivent TC Transcatheter Ventricular Enhancement System, which is used alongside the Less Invasive Ventricular Enhancement (LIVE) procedure. This system helps restore the shape and performance of the left ventricle in patients with ischemic heart failure. The company is also involved in the ALIVE Clinical Study, which evaluates the effectiveness of the Revivent TC System in treating symptomatic heart failure patients with specific types of left ventricular scarring. Additionally, BioVentrix offers comprehensive heart failure programs to assist hospitals in establishing integrated care models, including financial and operational plans. With headquarters in Mansfield, Massachusetts, and San Ramon, California, BioVentrix targets healthcare institutions and medical professionals specializing in cardiology.

800M+
監測企業
50+
本地數據來源
16
動向訊號
每日
更新頻率
「企業進駐市場的那一週,我們就接觸到他們——而非一季之後。」
增長主管 · Pubrio 上一支 500+ 人的營收團隊

洞察全球企業的每一步動向。

與我們的團隊預約一次動向地圖導覽。

pubrio

Pubrio 把橫跨 200+ 個市場的擴張訊號整合為一張即時圖譜,讓營收團隊看見哪些公司正進軍新市場,並把握時機。

追蹤

向 AI 了解 Pubrio

給 AI 代理

Pubrio - Agent Storefront, powered by ZeroClick

© 2026 Pubrio。版權所有。